NCT01968850View on ClinicalTrials.gov

Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 23, 2014

Primary Completion Date

March 19, 2018

Study Completion Date

March 19, 2018

Conditions
HIV
Interventions
DRUG

alendronate/vitamin D

once weekly 70mg oral dose of alendronate co-formulated with 5600IU vitamin D3 (cholecalciferol) for 24 weeks.

Trial Locations (2)

M5B 1W8

St. Michael's Hospital, Toronto

M5G 2N2

Toronto General Hospital, Toronto

All Listed Sponsors
collaborator

CIHR Canadian HIV Trials Network

NETWORK

lead

Unity Health Toronto

OTHER

NCT01968850 - Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial | Biotech Hunter | Biotech Hunter